This executive summary discusses in vitro methodologies used at Lonza for the characterization of bioavailability enhancing formulations, as well as criteria for selecting the right in vitro method based on compound properties and dose. To learn more, please download our executive summary.
Content Type: Whitepaper/Executive Summary
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

large mixer
Presentation (on-demand)
Particle Size Control Through Micronization: Challenges and Solutions
Micronization is an important technique in drug formulation, but not all substances are simple to...
Article
StarMab to Use Lonza’s XS® Pichia Platform to Express Their Proprietary Multifunctional VHH...
Beijing StarMab BioMed Technology Ltd. (StarMab) has entered a research evaluation agreement with...
Spray Drying Bend
Presentation (on-demand)
Dramatic Reduction of Solvent Usage in Pharmaceutical Spray Drying
Spray drying is a commonly used process for producing amorphous solid dispersions (ASDs) of drugs...
Multi-colored capules
Webinar (on-demand)
Improved Delivery of Poorly Soluble Compounds Using Capsule Formulations
In this webinar, two experts from Lonza will look at issues around drug solubility, and how...
HPAPI Trends Article Thumbnail
Video
Small Molecules Industry Trends
Interest in highly potent drugs is largely driven by oncology research and more targeted therapies...
Spray Drying - Bend
Whitepaper/Executive Summary
Driving Sustainability In Spray Drying Through Enabling Technologies
During drug development, various techniques can be applied to enhance the bioavailability of small...
Article
A Q&A With The Experts: New Technologies To Improve Solubility Of Brick Dust Compounds
In the webinar "Enabling Technologies to Increase Spray Drying Throughput for Brick Dust Compounds,"...
Article
Rapid Method Development to Overcome Challenges of Bi-specific Antibody Purification
The landscape of biopharmaceutical manufacturing is changing, with complex molecules such as...
Nansha - Leading HPAPI Innovations
eBook
Navigating the Drug Development Pipeline: Expertise for Highly Potent API Product Handling
Small molecules still represent the lion's share of the pharmaceutical market, despite the rise in...
Webinar (on-demand)
Key Enablers for Successful Late Phase Biologic Drug Product Development and Launch
Late-phase development of biologics is both the most time-intensive and costly stage of drug...
Inhalation moleculess
Webinar (on-demand)
Respiratory Delivery of Gemcitabine for the Treatment of Lung Cancer
In this webinar featuring experts from Quench Medical and Lonza Small Molecules, a case study of an...
women working on spray dryer
Webinar (on-demand)
Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
This webinar focuses on recent developments in spray drying technology that have allowed challenging...